SILDENAFIL IN NEONATES WITH PERSISTENT PULMONARY HYPERTENSION

• Research type

  Research Study

• Full title

  A multi-centre, randomised, placebo controlled double blind, two armed, parallel group study to evaluate efficacy and safety of IV Sildenafil in the treatment of neonates persistent pulmonary hypertension of the newborn (PPHN) or hypoxic respiratory failure and at risk for PPHN, with a long term flow up investigation of developmental progress 12 and 24 months after completion of study treatment

• IRAS ID

  112763

• Contact name

  Christine Marie Pierce

• Contact email

  Christine.Pierce@gosh.nhs.uk

• Sponsor organisation

  Pfizer Ltd

• Eudract number

  2012-002619-24

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  13/LO/0418

• Date of REC Opinion

  9 Jul 2013

• REC opinion

  Further Information Favourable Opinion